Prospective follow-up of New York City residents with e-cigarette, or vaping product use-associated lung injury-2020-2021.

ABSTRACT:

Background

A multistate outbreak of e-cigarette, or vaping, product use-associated lung injury (EVALI) occurred in 2019. Because of EVALI's novelty and severity, the New York City (NYC) Department of Health and Mental Hygiene (DOHMH) prospectively assessed sequelae among NYC residents who received an EVALI diagnosis in 2019.

Methods

Using existing NYC EVALI surveillance data, DOHMH attempted contact with all living residents who received an EVALI diagnosis in 2019 and conducted 3 waves of telephone interviews during April 2020-March 2021. Interview questions were adapted from the Centers for Disease Control and Prevention's EVALI case report form and validated surveys. Baseline differences between respondents and nonrespondents were assessed with Chi-square and Fisher's exac

SUBMITTER: Tannert Niang KM 

PROVIDER: S-EPMC12043135 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature